About VRI | Contact | People | Advisors | Reports | News | Phase I Trial | Press Releases

Reports to shareholders
In accord with the need to both conserve resources and minimise environmental impact, the Board has decided to increase VRi’s reporting intervals from three to six months. In future, unaudited management accounts for the six months between December 31st and June 30th will be posted on the Company’s website only and a hard copy of audited annual accounts will be sent to shareholders as soon as possible after the year end of 31st December.
11th October 2009

Fundraising
Our current funding round is now completed, surpassing its target of £750,000 to reach £760,000 gross. This financing was carried out by Charles Street Securities Europe LLP., to whom we are very grateful. Scientific research has now re-started and we are working towards a larger fundraising to support further clinical trials.
30th September 2009

New Chief Executive appointed
We are pleased to announce the appointment of Mr Richard Llewellyn as our new Chief Executive. Richard has been our Director of Corporate Development since September 2007 and was appointed CEO (part time) in February 2009. He has successfully steered the Company through its recent funding round and we look forward to working with him as we move forward.
27th February 2009

New non-executive Director appointed
We are pleased to announce the appointment of Dr Jean-Marc Saffar as a non-executive Director. Dr Saffar has been associated with the Company as a consultant for some years in the areas of marketing and fundraising.
25th February 2009

New non-executive Director appointed
We are pleased to announce the appointment of Mr Gilead Raday as a new non-executive Director. Gilead has previously acted as a consultant to the Company in the area of market research.
25th February 2009


Chairman
Mr Russell Stevens, who is currently a non-executive Director has been appointed Chairman to succeed Mr John Palethorpe who has, with regret, resigned his posts due to pressure of other commitments. John had served as non-executive Director and Chairman since the inception of the Company in 2002; we are greatly indebted to him for his commitment to VRi over the years and we wish him success in his current ventures.
25th February 2009  

Non-executive Director
Dr Joginderpal (Jag) Singh Kundi PhD ACMA MBA has resigned from the Board due to pressure of other commitments. We thank him for his support since September 2007. 
25th February 2009